COLD LIQUID GRAPE FLAVOUR 2 MG / 5 ML
BROMPHENIRAMINE MALEATE : 2 MG / 5 ML PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML · DIN 02315475 · CELLCHEM PHARMACEUTICALS INC.
Health Canada status: DORMANT
What is COLD LIQUID GRAPE FLAVOUR?
COLD LIQUID GRAPE FLAVOUR 2 MG / 5 ML contains BROMPHENIRAMINE MALEATE : 2 MG / 5 ML PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02315475, held by CELLCHEM PHARMACEUTICALS INC., supplied as SOLUTION for ORAL administration. Health Canada currently lists it as dormant, status dated 30-Jul-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02315475 |
|---|---|
| Brand name | COLD LIQUID GRAPE FLAVOUR |
| Generic / active ingredient | BROMPHENIRAMINE MALEATE : 2 MG / 5 ML PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML |
| Manufacturer | CELLCHEM PHARMACEUTICALS INC. |
| Strength | 2 MG / 5 ML |
| Dosage form | SOLUTION |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA53 PHENYLEPHRINE, COMBINATIONS |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 30-Jul-2020 |
What can be used instead?
Other Canadian products sharing ATC code R01BA53 PHENYLEPHRINE, COMBINATIONS. 0 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTIFED PE | 4 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02273845 |
| CHILDREN'S BENADRYL-D SYRUP | 12.5 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02280612 |
| COLD & STUFFY NOSE | 2.5 MG / 5 ML | LIQUID | ACCUDIAL PHARMACEUTICAL INC | CANCELLED POST MARKET | DIN 02328402 |
| COLD LIQUID | 2 MG / 5 ML | SOLUTION | TANTA PHARMACEUTICALS INC | DORMANT | DIN 02267411 |
| COLD LIQUID | 2 MG / 5 ML | SOLUTION | ARA-AVANTI RX ANALYTICS INC | CANCELLED PRE MARKET | DIN 02468212 |
| COLD SYRUP | 5 MG / 5 ML | SYRUP | JAMP PHARMA CORPORATION | DORMANT | DIN 02266180 |
| DIMETAPP | 5 MG / 5 ML | SYRUP | FOUNDATION CONSUMER BRANDS, LLC | CANCELLED POST MARKET | DIN 02243980 |
| DIMETAPP CHEWABLES FOR KIDS | 2.5 MG | TABLET (CHEWABLE) | PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02277239 |
| DIMETAPP EXTRA STRENGTH | 10 MG / 5 ML | SYRUP | FOUNDATION CONSUMER BRANDS, LLC | CANCELLED POST MARKET | DIN 02245075 |
| DIMETAPP ORAL INFANT COLD DROPS | 0.5 MG | LIQUID | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | DIN 02243945 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.